Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Report

6,817 Followers

VRTX Q2 2024 EPS Results

Actual EPS-$12.83

Consensus EPS-$11.63

Beat/MissMissed by -$1.20

One Year Ago EPS$3.89

Actual Revenue$2.63B

Expected Revenue$2.66B

Beat/MissMissed by -$28.96M

YoY Revenue Growth+6.02%

QuarterQ2 2024

Date08/01/2024

TimeAfter Close

Conference CallThursday, August 1, 2024

VRTX Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

VRTX Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	4.76 / -	4.8	―
Aug 03, 2026	2026 (Q2)	4.74 / 4.73	4.52	4.65% (+0.21)
May 04, 2026	2026 (Q1)	4.24 / 4.47	4.06	10.10% (+0.41)
Feb 12, 2026	2025 (Q4)	5.11 / 5.03	3.98	26.38% (+1.05)
Nov 03, 2025	2025 (Q3)	4.57 / 4.80	4.38	9.59% (+0.42)
Aug 06, 2025	2025 (Q2)	4.29 / 4.52	-12.83	135.23% (+17.35)
May 05, 2025	2025 (Q1)	4.32 / 4.06	4.76	-14.71% (-0.70)
Feb 10, 2025	2024 (Q4)	4.02 / 3.98	4.2	-5.24% (-0.22)
Nov 04, 2024	2024 (Q3)	4.08 / 4.38	4.08	7.35% (+0.30)
Aug 01, 2024	2024 (Q2)	-11.63 / -12.83	3.89	-429.82% (-16.72)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed